Inflammatory myofibroblastic tumors (IMTs) of the stomach are extremely rare in adults, and their oncologic prognosis is not well understood. We present a 28-year-old man with a proximal gastric IMT. The patient visited the emergency department of Yeouido St. Mary's Hospital with syncope and hematemesis. Hemoglobin levels were <5.5 g/dl. Gastric fibroscopy showed a protruding mass 4×4 cm in size, with central ulceration on the posterior wall of the fundus and diffuse wall thickening throughout the cardia and anterior wall of the upper body. Endoscopic biopsy revealed indeterminate spindle cells, along with inflammation. Given the risk of rebleeding, an operation was performed despite the uncertain diagnosis. Because the mass was circumferential, laparoscopic proximal gastrectomy and doubletract anastomosis were performed to ensure a safe resection margin. The pathological diagnosis was consistent with an IMT originating from the stomach, although the tumor was negative for anaplastic lymphoma kinase gene mutation.
Introduction
Inflammatory myofibroblastic tumors (IMTs) are rare neoplasms that occur preferentially in children and young adults. 1 IMTs most commonly occur in the lungs, mesenteries, omentum, and retroperitoneum. 1, 2 IMTs involving the stomach are extremely rare.
These distinctive tumors are composed of myofibroblastic cells accompanied by an inflammatory infiltrate of plasma cells, lymphocytes, and eosinophils. 3 IMTs present with nonspecific clinical symptoms, and their preoperative diagnosis can be difficult. IMTs in the gastrointestinal tract can present with bleeding, obstruction, anemia, or intussusception, depending on the site. 4 Herein, we present a case of an IMT that involved nearly the entire proximal stomach. The patient underwent laparoscopic proximal gastrectomy with double-tract anastomosis.
Case Report
A 28-year-old man presented with syncope and hematemesis.
His symptoms were not associated with abdominal pain, dyspepsia, fever, or weight loss. The patient had no notable medical or op- 
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stromal tumor, leiomyoma, and neurogenic tumor. In addition, immunoglobulin G4 (IgG4)-related sclerosing disease could be ruled out because IgG4/IgG ratio was less than 0.4 (Fig. 4) . Finally, the tumor was diagnosed as an IMT. The patient showed an uneventful postoperative course, and no local recurrence or distant metastasis was found during the 18-month follow-up.
Discussion
IMT was first described in 1937 as a primary lung tumor and has since been reported in various sites, including the mesenteries, the retroperitoneum, and the gastrointestinal tract. 4 It mainly occurs in young adults and children, and the lung is the most frequent location. Various terms have been used to describe this entity, such as 'inflammatory pseudotumor,' 'pseudosarcomatous myofibroblastic proliferation,' and 'plasma cell granuloma.' IMT is now considered a true tumor, not a pseudotumor.
Gastric IMT is a very rare condition. According to a recent review, primary gastric IMTs have been reported in only 17 adult patients. 5 The pathogenesis of IMT is unclear. Allergic, immunologic, and infectious reactions have been postulated. 6 Approximately half of IMTs harbor a clonal cytogenetic aberration that activates the ALK tyrosine kinase receptor gene on the 2p locus of chromosome 23. 7 Rearrangement of the ALK gene is another postulated pathogenesis.
Manifestations of gastric IMT may include abdominal pain, hematemesis, melena, a palpable mass, anemia, and high fever. A B *
